# T Cells in Predicting Acute Graft-Versus-Host Disease in Patients Undergoing Donor Stem Cell Transplant

> **NCT00651716** · — · TERMINATED · sponsor: **Vanderbilt-Ingram Cancer Center** · enrollment: 150 (actual)

## Conditions studied

- Breast Cancer
- Chronic Myeloproliferative Disorders
- Gestational Trophoblastic Tumor
- Leukemia
- Lymphoma
- Multiple Myeloma and Plasma Cell Neoplasm
- Myelodysplastic Syndromes
- Myelodysplastic/Myeloproliferative Neoplasms
- Neuroblastoma
- Ovarian Cancer
- Testicular Germ Cell Tumor

## Interventions

- **OTHER:** flow cytometry
- **OTHER:** laboratory biomarker analysis
- **OTHER:** Data Collection

## Key facts

- **NCT ID:** NCT00651716
- **Lead sponsor:** Vanderbilt-Ingram Cancer Center
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2006-12
- **Primary completion:** 2019-10
- **Final completion:** 2019-10
- **Target enrollment:** 150 (ACTUAL)
- **Why stopped:** Funding unavailable
- **Last updated:** 2019-11-15

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00651716

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00651716, "T Cells in Predicting Acute Graft-Versus-Host Disease in Patients Undergoing Donor Stem Cell Transplant". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT00651716. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*